127
Participants
Start Date
May 31, 2015
Primary Completion Date
March 31, 2025
Study Completion Date
June 30, 2025
Inspire® UAS System
This is a single-arm study; all participants will be implanted with the Inspire® UAS System, which is a permanent, implantable therapy that consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the study subject receives a remote control to activate the therapy.
Weill Cornell Medicine, New York
University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania, Division of Sleep Medicine, Philadelphia
Thomas Jefferson University and Hospital, Philadelphia
Medical University of South Carolina, Charleston
South Miami Hospital, Miami
Tampa General Hospital, Tampa
The University of Alabama at Birmingham Medical Center, Birmingham
Kentucky Research Group, Louisville
University Hospitals, Cleveland
Cleveland Clinic Foundation, Cleveland
The Christ Hospital, Cincinnati
The University of Kansas Medical Center, Kansas City
University of Southern California, Los Angeles
Lead Sponsor
Inspire Medical Systems, Inc.
INDUSTRY